BPC-157, CJC-1295 and Ipamorelin are three of the most talked-about peptides in fitness and wellness circles. They show up constantly online, often alongside big promises about muscle growth, fat loss and faster recovery. This article takes a more measured look at what these peptides are, what they have been studied for, and what is still unknown.
An important note up front: none of these three peptides are FDA-approved for any use. Much of the available research is early-stage, and long-term safety in people has not been well established.
Peptides are short chains of amino acids. The body naturally produces many of them, and they often act as signaling molecules that help cells and tissues communicate. Some peptides are FDA-approved medications for specific conditions; others, including the three below, are considered research compounds.
BPC-157 (“Body Protection Compound-157”) is a synthetic peptide based on a sequence found in a protein in stomach fluid.
What it has been studied for: Most of the research on BPC-157 has been done in animals, looking at tendon, ligament, muscle and gut tissue healing. Some of those animal studies reported faster healing and increased blood-vessel formation at injury sites.
What is still unknown: High-quality clinical trials in people are very limited, so it isn’t known whether animal findings carry over to humans, what dose would be appropriate, or what the long-term risks might be.
CJC-1295 is a lab-made version of growth hormone–releasing hormone (GHRH), a signal that tells the pituitary gland to release growth hormone.
What it has been studied for: Small early human studies found that CJC-1295 can raise growth hormone and IGF-1 levels for an extended period after a single dose. Because growth hormone affects metabolism and body composition, it has drawn interest in that area.
What is still unknown: Raising hormone levels is not the same as producing proven health or body-composition benefits. Larger, longer studies in people are lacking, and artificially raising growth hormone signaling may carry risks that aren’t fully understood.
Ipamorelin is a synthetic peptide that also prompts the pituitary gland to release growth hormone, through a different pathway than CJC-1295. It is often described as more “selective” because in early studies it had less effect on other hormones such as cortisol.
What it has been studied for: Ipamorelin was tested in human clinical trials for a digestive condition after surgery, but it did not show enough benefit to be approved. Interest in it for body composition is based mostly on its effect on growth hormone rather than on direct evidence.
What is still unknown: There is little published clinical research on Ipamorelin for fitness, muscle or fat-loss goals, alone or combined with CJC-1295.
Peptides are an active area of research, and some findings are interesting. But the gap between early research and proven results in people is often large, and online claims tend to get ahead of the evidence. Nutrition, strength training, sleep and management of underlying health conditions remain the foundation of changes in body composition.
If you’ve been reading about peptides and want a balanced explanation of the research, including the risks and unknowns, we’re happy to talk. You can contact us or call (435) 900-1210. You can also read our peptide overview for more background.
This article is for general educational purposes only and is not medical advice. BPC-157, CJC-1295 and Ipamorelin are not FDA-approved to diagnose, treat, cure or prevent any disease. Talk with a licensed healthcare professional before starting any new treatment.
.png)